Latest filing published 29 Apr 2020 for Med BioGene Inc..
No signal scores available.
Iain Weir-Jones is a declared insider of Med BioGene Inc., with filings sourced from SEDI. Over a trading history stretching from 12 May 2016 to 27 April 2020, the count stands at 4 filings.
The open-market record is one-sided, with 1 purchase worth €3,762 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 29 April 2020 came the latest disclosure, a transaction in Med BioGene Inc. The latest purchase dates back some time: it was published 3,537 days ago, on 17 February 2017. Between a trade and the moment it shows up on SEDI, the median delay is 1 day. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations